Gerald Supinski, M.D.

Supinski GS, Callahan LA. Double-stranded RNA-dependent protein kinase activation modulates endotoxin-induced diaphragm weakness. J Appl Physiol. 2011;110(1):199-205.
Callahan LA, Supinski GS. Diaphragm weakness and mechanical ventilation – what’s the critical issue? Crit Care. 2010;14(4):187.
Supinski GS, Vanags J, Callahan LA. Eicosapentaenoic acid preserves diaphragm force generation following endotoxin administration. Crit Care. 2010;14(2):R35.
Supinski GS, Ji XY, Callahan LA. p38 Mitogen-activated protein kinase modulates endotoxin-induced diaphragm caspase activation. Am J Respir Cell Mol Biol. 2010;43(1):121-7.
Supinski GS, CallahanLA. Calpain activation contributes to endotoxin-induced diaphragmatic dysfunction. Am J Respir Cell Mol Biol. 1020;42(1):80-7.
Callahan LA, Supiniski GS. Sepsis-induced myopathy. Crit Care Med. 2009;37(10 Suppl):S354-67.
Supiniski GS, Wang W, Callahan LA. Caspase and calpain activation both contribute to sepsis-induced diaphragmatic weakness. J Appl Physiol. 2009;107(5):1389-96.
Supinski GS, Murphy MP, Callahan LA. MitoQ administration prevents endotoxin-induced cardiac dysfunction. Am J Physiol Regul Integr Comp Physiol. 2009;297(4):R1095-102.
Supinski GS, Ji X, Callahan LA. The JNK MAP kinase pathway contributes to the development of endotoxin-induced diaphragm caspase activation. Am J Physiol Regul Integr Comp Physiol, 2009;297(3):R825-34.
Callahan LA, Supinski GS. Hyperglycemia and acquired weakness in critically ill patients: potential mechanisms. Crit Care. 2009;13(2):125.